SCCA | Strategic Alliance Partners

January 07, 2021

Elena Gabriela Chiorean, MD, discusses the role of genetic testing in pancreatic cancer.

January 04, 2021

Julie Gralow, MD, discusses exciting research in HER2-positive breast cancer.

December 21, 2020

Michael Schweizer, MD, discusses the rationale for the phase 3 CARD trial in metastatic castration-resistant prostate cancer.

December 07, 2020

Michael Schweizer, MD, discusses the role of olaparib in patients with non–BRCA-mutant metastatic castration-resistant prostate cancer.

November 23, 2020

Daniel W. Lin, MD, discusses the limitations of currently available biomarkers in prostate cancer.

October 28, 2020

Christina Baik, MD, MPH, highlights the evolving role of EGFR inhibition in the NSCLC space.